High Fidelity Transcriptome Sequencing Tools
High Fidelity Transcriptome Sequencing Tools
批准号:
8123993
负责人:
Michael Joseph Lodes
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-12-31
关键词:
AffectAlcoholsArchivesAvian Myeloblastosis VirusBacteriophagesBase SequenceBioinformaticsBiological ProcessBiologyCellsCloningComplexDNADNA LibraryDNA SequenceDNA Sequence RearrangementDNA amplificationDNA biosynthesisDNA-Directed DNA PolymeraseDataData QualityDatabasesDengueDiseaseDropsEnzymesEscherichia coliFrequenciesFunctional RNAFundingFutureGelGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic CodeGenetic TranscriptionGoalsGuanine + Cytosine CompositionHIVHigh temperature of physical objectHot SpringsHumanHuman GenomeImmunizationInfluenzaInheritedIntegraseKnowledgeLaboratory ResearchLibrariesMalignant NeoplasmsManualsMessenger RNAMethodsMicrobeModelingMoloney Leukemia VirusMorphologic artifactsNucleotidesPatternPhasePoint MutationPolymerasePopulationPrecipitationPredispositionProcessProtocols documentationRNARNA Sequence AnalysisRNA SequencesRNA VirusesRNA libraryRNA-Directed DNA PolymeraseReagentResearchResearch PersonnelResistance developmentReverse Transcriptase Polymerase Chain ReactionReverse TranscriptionRibosomal RNASamplingSecondary toSequence AnalysisSomatic MutationSpeedStructureSystemTechniquesTechnologyTimeTranscriptTransfer RNATransferaseVirusWorkYeastsbasecancer cell differentiationchemotherapycostflexibilityhuman diseaseimprovedin vivonew technologynext generationnovelprogramsprototypethermostabilitytooltranscriptomicsvirus genetics
中文摘要
描述(由申请人提供):基因表达调控驱动所有生物过程。彻底了解控制基因表达模式的机制对于理解生物学基础以及癌症和其他疾病的复杂性是必要的。人类疾病研究的未来将基于人类基因组和转录组(所有RNA分子的集合,包括mRNA、rRNA、tRNA和在一个或一个细胞群中产生的非编码RNA)的下一代测序(NGS);并将依赖于DNA和RNA文库的准确序列表示。近年来,随着NGS的出现,DNA测序的成本大幅下降,这彻底改变了研究基因表达的方式。在这种新的范例中,转录组通过一类被称为逆转录酶的酶转化为互补DNA (cDNA)。核苷酸序列分析揭示了mrna的遗传密码以及许多只能通过RNA测序来研究的转录后过程步骤。这提供了所有表达基因的全面视图,以及通过传统方法无法获得的额外信息。NGS平台越来越强大和可靠;然而,这些技术在转录组测序中的应用尚不发达。转录组测序的一个关键步骤是,将所有RNA物种(转录本)转化为DNA (NGS系统中分析的材料)充满了技术困难,并且在低保真度逆转录酶的转化过程中受到复制错误、重排和偏差的影响。这种转换过程非常耗时,而且容易出现操作错误。通过对温泉中病毒和噬菌体遗传学长达十年的研究,Lucigen发现并开发了一种名为PyroScript RT的独特酶,与传统酶相比,该酶有望将RNA序列分析的准确性提高两个数量级,并大大减少重排的频率。高温优化的PyroScript RT也有望减少由于二级结构引起的偏置。我们打算使用这种酶来开发和验证转录组文库合成试剂盒,该试剂盒包含一个单一的、新颖的、高保真的聚合酶,用于RNA的逆转录和随后的DNA扩增。为了实现这一目标,我们将开发一种简单的cDNA文库合成方案,该方案灵活适用于所有主要的NGS平台,并基于PyroScript RT的独特品质,减少误结合产物和偏差。我们提出的研究结果将是一种试剂,它将允许小型和大型研究实验室在平等的基础上竞争,并通过更准确和公正的序列数据库推进转录组多样性的知识。
英文摘要
DESCRIPTION (provided by applicant): The regulation of gene expression drives all biological processes. A thorough understanding of the mechanisms governing the patterns of gene expression is necessary to understand the fundamentals of biology and the complexities of cancers and other diseases. The future of research into human disease will be based in next generation sequencing (NGS) of the human genome and transcriptome (the set of all RNA molecules, including mRNA, rRNA, tRNA, and non-coding RNA produced in one or a population of cells); and will be dependent on accurate sequence representation from DNA and RNA libraries. The cost of DNA sequencing has dropped dramatically in recent years with the advent of NGS and this has revolutionized the way that gene expression is studied. In this new paradigm, the transcriptome is converted to complimentary DNA (cDNA) by a class of enzyme known as reverse transcriptase. Nucleotide sequence analysis reveals the genetic code for mRNAs as well as numerous post transcriptional process steps that can only be studied by RNA sequencing. This provides a comprehensive view of all expressed genes, as well as additional information not available through traditional approaches. NGS platforms are increasingly robust and reliable; however, the adaption of these technologies for transcriptome sequencing is less developed. A key step in transcriptome sequencing, the conversion of all RNA species (the transcripts) to DNA (the material analyzed in the NGS systems) is laden with technical difficulties and compromised by copying errors, rearrangements and biases during the conversion by low fidelity reverse transcriptases. This conversion process is time consuming and prone to operator error. Through a decade-long program to study the genetics of viruses and phage in hot springs, Lucigen has discovered and developed a unique enzyme called PyroScript RT that promises to improve the accuracy of RNA sequence analysis by two orders of magnitude compared to conventional enzymes and greatly reduce the frequency of rearrangements. The high temperature optimum of PyroScript RT also promises to reduce bias due to secondary structures. We intend to use this enzyme to develop and validate transcriptome library synthesis kits that incorporate a single, novel, high fidelity polymerase for reverse transcription of RNA and subsequent DNA amplification. To achieve this goal we will develop a simple protocol for cDNA library synthesis that is flexible for all of the major NGS platforms and based on the unique qualities of PyroScript RT that will reduce misincorporation artifacts and bias. The result of our proposed study will be a reagent that will allow both the small and large research laboratory to compete on equal grounds and advance the knowledge of transcriptome diversity through a more accurate and unbiased sequence database.
PUBLIC HEALTH RELEVANCE: The human genome and transcriptome (transcribed RNA) contain information relevant to human disease. With the advent of next-generation sequencing and improved bioinformatics analysis techniques, we are able to more rapidly characterize disease samples and thus increase our understanding of the susceptibility and onset of inherited diseases, the somatic mutations that initiate cancers and the identity of pathogenic microbes that affect humans. New tools are needed to improve the accuracy, eliminate rearrangements and reduce the bias of transcriptomics research as well as simplified kits that provide easy access to next-generation sequencing to all researchers. The funding provided for this project will help us develop these tools and help speed the research on human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Tools for Structural Variation Analysis, De Novo Assembly and Closing of Complex Genomes
-
批准号:8833641
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2014
-
负责人:Michael Joseph Lodes
-
依托单位:
海外基金